04:56 PM EST, 03/05/2024 (MT Newswires) -- Sarah Boyce, Director, President and CEO, on March 01, 2024, sold 84,000 shares in Avidity Biosciences ( RNA ) for $1,691,306. Following the Form 4 filing with the SEC, Boyce has control over a total of 112,117 shares of the company, with 112,117 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1599901/000159990124000038/xslF345X03/wk-form4_1709675574.xml
Price: 19.52, Change: +0.38, Percent Change: +1.99